Doxycycline, salinomycin, monensin and ivermectin repositioned as cancer drugs.

Markowska, Anna; Kaysiewicz, Joanna; Markowska, Janina; Huczynski, Adam

Markowska, Anna; Kaysiewicz, Joanna; Markowska, Janina; Huczynski, Adam.

Afiliação

Markowska A; Department of Perinatology and Women's Diseases, Poznan University of Medical Sciences, Polna 33, 60-545 Poznan, Poland.
Kaysiewicz J; Roche Poland, Domaniewska 39b, 02-672 Warsaw, Poland.
Markowska J; Department of Oncology, Poznan University of Medical Sciences, Szamarzewskiego 82/84, 60-569 Poznan, Poland.
Huczynski A; Department of Bioorganic Chemistry, Faculty of Chemistry, Adam Mickiewicz University, Umultowska 89b, 61-614 Poznan, Poland. Electronic address: adhucz@amu.edu.pl.

Bioorg Med Chem Lett ; 29(13): 1549-1554, 2019 07 01.

Article em En | MEDLINE | ID: mdl-31054863

Assuntos

Antineoplásicos/uso terapêutico; Doxiciclina/uso terapêutico; Ivermectina/uso terapêutico; Monensin/uso terapêutico; Neoplasias/tratamento farmacológico; Piranos/uso terapêutico; Antineoplásicos/farmacologia; Doxiciclina/farmacologia; Humanos; Ivermectina/farmacologia; Monensin/farmacologia; Piranos/farmacologia

Palavras-chave

Anticancer antibiotic; Cancer stem cells; New anticancer agent; Off-target effect

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Piranos / Ivermectina / Monensin / Doxiciclina / Neoplasias / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google